Position in VKTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,089,389
+$5,239,042 QoQ
Shares Held
525,181
+55.9% QoQ
Ownership
0.452%
of shares outstanding
% of Portfolio
7.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Derivatives in VKTX
reported options exposure · as of Mar 31, 2026CallValue
$21,450,368
CallShares
659,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIADEMA PARTNERS LP holds $176,357,038 across 73 Biotechnology names. VKTX ranks #1 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
This page
|
525,181 | $17,089,389 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
322,764 | $12,423,186 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
54,755 | $10,351,432 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
181,752 | $9,581,965 | |
| 5 | ABVX |
Abivax S.A.
|
75,944 | $8,456,364 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
148,229 | $8,373,456 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
80,872 | $7,864,802 | |
| 8 | KOD |
Kodiak Sciences Inc.
|
192,962 | $7,355,711 |
All Filings in VKTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,450,368 | 659,200 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $17,089,389 | 525,181 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,235,502 | 688,900 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $11,850,347 | 336,849 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $11,141,506 | 316,700 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $10,646,028 | 405,100 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $5,090,146 | 193,689 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,232,902 | 197,468 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,514,522 | 104,121 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $1,207,500 | 50,000 | Call | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||